Filter by:
Caption
Inside Virginia’s Rise to Biopharma Prominence
As the world continues to struggle with drug supply chains and critical shortages, clusters of activity have emerged to move the needle of medication affordability and accessibility.
Caption
Inside Virginia’s Rise to Biopharma Prominence
As the world continues to struggle with drug supply chains and critical shortages, clusters of activity have emerged to move the needle of medication affordability and accessibility.
A Biopharma Moment Decades in the Making
John Newby is the CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in Virginia.
A Biopharma Moment Decades in the Making
John Newby is the CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in Virginia.
Enabling Innovation
Would more men try to prevent unintended pregnancies if their choices for contraception went beyond a condom or vasectomy?
Hopewell Riverwalk
The Communities at the Forefront of Virginia’s Biopharma Push: The I95-I85 Intersection
The I95-I85 Intersection is anchored by the Tri-Cities of Petersburg (home to Civica Rx’s facility that produces a wide variety of affordable essential medicines), Hopewell, and Colonial Heights.
The Investments Behind a Biopharma Hotspot
A lot changed in Virginia’s life sciences industry in the space of about a month last fall. Between Sept. 16 and Oct. 20, biopharmaceutical manufacturing giants Eli Lilly and Company, AstraZeneca, and Merck & Co.
Continuous Improvement
A pharmaceutical manufacturing innovation that came out of a Virginia university is changing the way medicines are made. The Commonwealth’s universities and the rest of its biopharma research community are making sure Virginia is ready to make the medicines of the future.
Enabling Innovation
Would more men try to prevent unintended pregnancies if their choices for contraception went beyond a condom or vasectomy?
Behind the Effort to Bring Drug Manufacturing Back to U.S. Shores
In October 2025, shovels went into the ground in Elkton, marking the start of a $3 billion pharmaceutical expansion project that will add 400,000 square feet to Merck’s existing campus.
The Urgency of Building Healthier Communities
Pam Cheng is executive vice president of global operations and IT and chief sustainability officer at AstraZeneca, which recently announced a new facility in Albemarle County — the company’s first in Virginia.
The Investments Behind a Biopharma Hotspot
A lot changed in Virginia’s life sciences industry in the space of about a month last fall. Between Sept. 16 and Oct. 20, biopharmaceutical manufacturing giants Eli Lilly and Company, AstraZeneca, and Merck & Co.
Building a Sustainable Pharma Manufacturing Workforce
Recent major biopharmaceutical manufacturing announcements are positioning Virginia for a broader reshoring effort in the pharma industry. COVID-era supply chain disruptions and resulting shortages exposed the risks of over-reliance on overseas production for essential medicines.
Continuous Improvement
A pharmaceutical manufacturing innovation that came out of a Virginia university is changing the way medicines are made. The Commonwealth’s universities and the rest of its biopharma research community are making sure Virginia is ready to make the medicines of the future.
Pharmaceutical manufacturer Civica Rx expanded into Virginia in 2021, building a sterile injectable drug manufacturing facility in Petersburg. The company turned to the Virginia Talent Accelerator Program to fill approximately 300 positions.
Bespoke Training for Emerging Workforce Needs
New or expanding companies want to know that they will be able to hire workers with the skills they need. While outside training providers offer established but generic faculty, facilities, and programs, in-house solutions allow for customization but require significant investment.
The Art and Science of Commercialization
Drake Goolsby is chief commercialization officer at Luna Labs, a Charlottesville-based company that helps develop advanced technologies in biotech, advanced materials, and engineered systems for government, military, and industrial clients.
Haleon, Richmond
A Biopharma Booster
Like his fellow Type 1 diabetics, Alec Smith took insulin every day to regulate his blood sugar.
Haleon, Richmond
A Biopharma Booster
Like his fellow Type 1 diabetics, Alec Smith took insulin every day to regulate his blood sugar.
